These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3782829)

  • 1. [Study of the DNA content of 72 cases of bladder tumors using flow cytometry. Relation with anatomoclinical data].
    Devonec M; Hijazi A; Muchada E; Bouvier R; Dubernard JM
    J Urol (Paris); 1986; 92(4):223-30. PubMed ID: 3782829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new hypothesis on the natural history of bladder cancer based on the study of tumor DNA levels by flow cytometry].
    Devonec M
    Ann Urol (Paris); 1987; 21(4):250-6. PubMed ID: 3674785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical cancer progression in urinary bladder tumors evaluated by multiparameter flow cytometry with monoclonal antibodies. Laval University Urology Group.
    Fradet Y; Tardif M; Bourget L; Robert J
    Cancer Res; 1990 Jan; 50(2):432-7. PubMed ID: 2295082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].
    Xue J
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):650-3, 700. PubMed ID: 2632194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry analysis of urothelial cell DNA content according to pathological and clinical data on 100 bladder tumors.
    Caratero C; Hijazi A; Caratero A; Mazerolles C; Rischmann P; Sarramon JP
    Eur Urol; 1990; 18(2):145-9. PubMed ID: 2226584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prognostic value of cytofluorometry in bladder tumors].
    Verine JL; Coic H; Bertrand G; Lépinard V; Soret JY
    Ann Urol (Paris); 1986; 20(3):175-85. PubMed ID: 3729300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic value of flow cytometry of bladder lavage in the surveillance of bladder tumors].
    Hijazi A; Devonec M; Muchada E; Dubernard JM; Revillard JP
    J Urol (Paris); 1987; 93(1):11-20. PubMed ID: 3559255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of ploidy level in bladder tumors and selected site specimens by flow cytometry.
    Jakobsen A; Mommsen S; Olsen S
    Cytometry; 1983 Sep; 4(2):170-3. PubMed ID: 6628139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Flow cytometry in cancer of the bladder].
    Chassevent A; Allain YM; Chautard D; Larra F; Lépinard V; Soret JY
    Cancer Radiother; 1998 Apr; 2 Suppl 1():12s-15s. PubMed ID: 9749070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
    Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
    Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric studies on the relationship between DNA content and clinicopathologic features of pancreatic cancers.
    Bocsi J; Berczi C; Balázs G; Lapis K
    Anticancer Res; 1998; 18(3A):1839-43. PubMed ID: 9673413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry.
    Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G
    Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of DNA content in epithelial ovarian cancer.
    Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
    Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA in situ sensitivity to denaturation as a marker of human breast tumors.
    Kunicka JE; Olszewski W; Rosen PP; Kimmel M; Melamed MR; Darzynkiewicz Z
    Cancer Res; 1989 Nov; 49(22):6347-51. PubMed ID: 2804980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA in situ sensitivity to denaturation in bladder cancer and its correlation with tumor stage.
    Bretton PR; Darzynkiewicz Z; Henry E; Kimmel M; Fair WR; Melamed MR
    Cancer Res; 1990 Dec; 50(24):7912-4. PubMed ID: 2253231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.